Julia Asp
Overview
Explore the profile of Julia Asp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
508
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bohmer J, Wahlander H, Karason K, Sunnegardh J, Wasslavik C, Jonsson M, et al.
Clin Transplant
. 2024 Oct;
38(10):e15477.
PMID: 39422356
Objective: Cell-free DNA (cfDNA) is used as a biomarker after transplantation to detect graft injury, relying on the donor fraction (DF). We have established a PCR-based approach allowing us to...
2.
Bohmer J, Wasslavik C, Andersson D, Stahlberg A, Jonsson M, Wahlander H, et al.
Transpl Int
. 2023 Nov;
36:11260.
PMID: 37965628
In this prospective study we investigated a cohort after heart transplantation with a novel PCR-based approach with focus on treated rejection. Blood samples were collected coincidentally to biopsies, and both...
3.
Pettersson H, Adamsson J, Johansson P, Nilsson S, Palmqvist L, Andreasson B, et al.
Front Oncol
. 2023 Aug;
13:1190305.
PMID: 37637067
Introduction: Myeloproliferative neoplasm (MPN) is a heterogenous group of hematological malignancies including polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF). V617F is the most frequent driver mutation in...
4.
Nilsson T, Waraky A, Ostlund A, Li S, Staffas A, Asp J, et al.
Int J Cancer
. 2022 May;
151(5):770-782.
PMID: 35583991
Acute myeloid leukemia (AML) results from aberrant hematopoietic processes and these changes are frequently initiated by chromosomal translocations. One particular subtype, AML with translocation t(7;12)(q36;p13), is found in children diagnosed...
5.
Pettersson L, Johansson Alm S, Almstedt A, Chen Y, Orrsjo G, Shah-Barkhordar G, et al.
Int J Lab Hematol
. 2021 May;
43(4):664-674.
PMID: 34053184
Introduction: Reverse transcriptase quantitative PCR (RT-qPCR) is considered the method of choice for measurable residual disease (MRD) assessment in NPM1-mutated acute myeloid leukemia (AML). MRD can also be determined with...
6.
Andreasson B, Pettersson H, Wasslavik C, Johansson P, Palmqvist L, Asp J
Br J Haematol
. 2020 Feb;
189(5):913-919.
PMID: 32066200
Polycythaemia vera (PV) patients have an overall comparatively favourable prognosis, but disease progression is very heterogeneous and life-threatening thrombosis and bleedings are frequent complications in untreated disease. Moreover, transformation to...
7.
Synnergren J, Vukusic K, Donnes P, Jonsson M, Lindahl A, Dellgren G, et al.
Physiol Genomics
. 2019 Dec;
52(2):110-120.
PMID: 31869284
Transcriptional studies of the human heart provide insight into physiological and pathophysiological mechanisms, essential for understanding the fundamental mechanisms of normal cardiac function and how they are altered by disease....
8.
Asp J, Skov V, Bellosillo B, Kristensen T, Lippert E, Dicker F, et al.
Ann Hematol
. 2018 Dec;
98(5):1111-1118.
PMID: 30535576
External quality assurance (EQA) programs are vital to ensure high quality and standardized results in molecular diagnostics. It is important that EQA for quantitative analysis takes into account the variation...
9.
Delsing Malmberg E, Rehammar A, Pereira M, Abrahamsson J, Samuelsson T, Stahlman S, et al.
J Mol Diagn
. 2018 Oct;
21(1):149-162.
PMID: 30273780
Minimal residual disease (MRD) in acute myeloid leukemia (AML) is of major prognostic importance. The genetic landscape of AML is characterized by numerous somatic mutations, which constitute potential MRD markers....
10.
Delsing Malmberg E, Johansson Alm S, Nicklasson M, Lazarevic V, Stahlman S, Samuelsson T, et al.
Leuk Lymphoma
. 2018 Aug;
60(2):409-417.
PMID: 30068244
Mutations in NPM1 can be used for minimal residual disease (MRD) analysis in acute myeloid leukemia (AML). We here applied a newly introduced method, deep sequencing, allowing for simultaneous analysis...